Wave Life Sciences
WVE
23 hedge funds and large institutions have $192M invested in Wave Life Sciences in 2016 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
21% more funds holding
Funds holding: 19 → 23 (+4)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
12% less capital invested
Capital invested by funds: $219M → $192M (-$26.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$2.46M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.43M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
+$345K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$151K |
| 5 |
Morgan Stanley
New York
|
+$38.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.2M |
| 2 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$277K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$75K |
| 4 |
Goldman Sachs
New York
|
-$24.9K |
| 5 |
Norges Bank
Oslo,
Norway
|
-$14K |
WVE Hedge Fund Activity: Q1 2016 in Review
23 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q1 2016, worth a combined $192M — down 12% from $219M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new WVE positions and 1 closed out — a net gain of 4 holders — while 6 added to existing stakes and 6 trimmed.
The largest buyer was Perceptive Advisors, opening a new position worth an estimated $2.46M. The largest seller was Fidelity Investments, cutting an estimated $1.2M.
- 23 institutional investors held Wave Life Sciences (WVE) as of Q1 2016, up from 19 in Q4 2015.
- Funds reported $192M of Wave Life Sciences stock for Q1 2016, down 12% quarter-over-quarter.
- 5 funds opened new Wave Life Sciences positions in Q1 2016 and 1 closed out, a net change of +4 holders.
- The largest Wave Life Sciences buyer in Q1 2016 was Perceptive Advisors, an estimated $2.46M added.
- The largest Wave Life Sciences seller in Q1 2016 was Fidelity Investments, an estimated $1.2M sold.
Based on aggregated 13F filings for Q1 2016.